EHMT2 and glioblastoma: The expression of G9a in glioblastoma cells was decreased after inhibitor treatment (Figure 1I) and G9a-shRNA-induced gene knockdown, and the no.1 shG9a had the higher effectivity in knockdown G9a expression (Figure 1B).